A novel telomerase activator suppresses lung damage in a murine model of idiopathic pulmonary fibrosis. | Profiles RNS

RCMI Coordinating Center (RCMI CC)

A novel telomerase activator suppresses lung damage in a murine model of idiopathic pulmonary fibrosis.

Le Saux CJ, Davy P, Brampton C, Ahuja SS, Fauce S, Shivshankar P, Nguyen H, Ramaseshan M, Tressler R, Pirot Z, Harley CB, Allsopp R. A novel telomerase activator suppresses lung damage in a murine model of idiopathic pulmonary fibrosis. PLoS One. 2013; 8(3):e58423.

View in: PubMed

authors with profiles

Richard Allsopp, PhD

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support